title: Regulation of bovine interleukin-1 receptors.
abstract: Interleukin-1 is a key player in inflammation and the immune response. The interleukin-1 family consists of three ligands (IL-1 alpha, IL-1 beta, and the IL-1 receptor antagonist) and two receptors (IL-1RI and IL-1RII). Previous studies suggest a dynamic relationship among these receptors and ligands that regulates the magnitude and extent of IL-1 mediated activities. Our laboratory has cloned and sequenced the bovine type I and II interleukin-1 receptors, and has begun to investigate their regulation in bovine leukocytes in vitro and in vivo. IL-1RI and IL-1RII mRNA levels were upregulated in vitro by various mediators, including dexamethasone, rBoIL-4, rBoGM-CSF, and rHuTNF alpha. Conversely, IL-1RI mRNA levels were down-regulated by IFN-gamma. An in vivo study indicated that IL-1RII mRNA levels increased earlier than IL-1RI mRNA levels in dexamethasone-treated cattle. These findings suggest that early upregulation of IL-1RII, which is a decoy receptor, may be part of the anti-inflammatory action of glucocorticoids. Our investigations suggest that anti-inflammatory agents increase expression of the biologically inactive IL-1RII, as compared with the biologically active IL-1RI, in bovine leukocytes.
authors.affiliation: University of Wisconsin-Madison, School of Veterinary Medicine, WI 53706, USA.
authors.forename: P W
authors.initials: PW
authors.lastname: Yu
authors.forename: L A
authors.initials: LA
authors.lastname: Schuler
authors.forename: J J
authors.initials: JJ
authors.lastname: Rejman
authors.forename: H T
authors.initials: HT
authors.lastname: Chen
authors.forename: K
authors.initials: K
authors.lastname: Gosink
authors.forename: M
authors.initials: M
authors.lastname: Kehrli
authors.forename: L
authors.initials: L
authors.lastname: Mattocks
authors.forename: B
authors.initials: B
authors.lastname: Nonnecke
authors.forename: C J
authors.initials: CJ
authors.lastname: Czuprynski
mesh_terms: D000818:Animals; D002417:Cattle / Q000276:immunology*; D003907:Dexamethasone / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D066298:In Vitro Techniques; D018836:Inflammation Mediators / Q000276:immunology; D007375:Interleukin-1 / Q000276:immunology; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D017472:Receptors, Interleukin-1 / Q000235:genetics / Q000378:metabolism*; D053573:Receptors, Interleukin-1 Type I; D053574:Receptors, Interleukin-1 Type II
chemical_list: D018836:Inflammation Mediators; D007375:Interleukin-1; D012333:RNA, Messenger; D017472:Receptors, Interleukin-1; D053573:Receptors, Interleukin-1 Type I; D053574:Receptors, Interleukin-1 Type II; D003907:Dexamethasone